Sweden – Medical equipments, pharmaceuticals and personal care products – NAT Instrument och reagenser

This is a framework agreement for NAT (Nucleic Acid Testing) instruments and reagents, issued by Adda Inköpscentral AB on behalf of Swedish public entities. It is an open procedure with a single lot, valued at SEK 1.6 billion, covering a broad range of medical equipment CPVs. The contract duration is 4 years from September 2026. Submission is electronic, in Swedish only, with a deadline of 18 August 2026. The procurement documents are available via tendsign but were not analyzed. No selection or award criteria were provided in the notice.